PAVmed Inc.
PAVM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -16.7% | -25% | -20% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,000% | -583.3% | -887.5% | -380% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $4 | $4 | $4 | $4 |
| SG&A Expenses | $4 | $4 | $5 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | $0 |
| Operating Expenses | $5 | $5 | $5 | $5 |
| Operating Income | -$5 | -$5 | -$5 | -$5 |
| % Margin | -96,880% | -78,583.3% | -68,075% | -51,870% |
| Other Income/Exp. Net | -$1 | -$8 | $24 | $6 |
| Pre-Tax Income | -$6 | -$12 | $19 | $1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5 | -$12 | $19 | $1 |
| % Margin | -107,660% | -198,683.3% | 237,100% | 14,310% |
| EPS | -0.29 | -0.74 | 1.275 | 0.12 |
| % Growth | 60.8% | -158% | 960.9% | – |
| EPS Diluted | -0.29 | -0.74 | 0.337 | 0.12 |
| Weighted Avg Shares Out | 22 | 18 | 14 | 11 |
| Weighted Avg Shares Out Dil | 22 | 18 | 52 | 11 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$6 | -$12 | $19 | $1 |
| % Margin | -119,620% | -204,966.7% | 233,375% | 12,180% |